Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -31.951% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) COc1ccccc1CN1CC(C(=O)N2CCN(c3ccc(F)cc3)CC2)CC1=O
b.) CCN(CC)CCCn1c2c(c(SCC(=O)Nc3nccs3)nc1=O)CCC2
Answer: b. CCN(CC)CCCn1c2c(c(SCC(=O)Nc3nccs3)nc1=O)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)CCCn1c2c(c(SCC(=O)Nc3nccs3)nc1=O)CCC2
CCN(CC)CCCn1c2c(c(SCC(=O)Nc3nccs3)nc1=O)CCC2
2-[[1-[3-(diethylamino)propyl]-2-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]sulfanyl]-N-(1,3-thiazol-2-yl)acetamide